Dr Stephen Carl Klass, MD | |
421 Huguenot St, New Rochelle, NY 10801-7004 | |
(914) 636-4418 | |
(914) 636-2975 |
Full Name | Dr Stephen Carl Klass |
---|---|
Gender | Male |
Speciality | Neurology |
Experience | 53 Years |
Location | 421 Huguenot St, New Rochelle, New York |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1518980960 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2084N0400X | Psychiatry & Neurology - Neurology | 123891 (New York) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Montefiore New Rochelle Hospital | New rochelle, NY | Hospital |
New York-presbyterian Hospital | New york, NY | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Montefiore New Rochelle Hospital | 0345474706 | 60 |
News Archive
Arno Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing oncology therapeutics, today announced the dosing of the first patient in an investigator sponsored Phase I/IIa clinical study of AR-42 (formerly OSU-HDAC42) at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC-James) in adult patients with relapsed or refractory multiple myeloma (MM), chronic lymphocytic leukemia (CLL) or lymphoma.
The measure, which awaits the president's signature, puts off large cuts in federal spending and increases taxes. But it delays efforts to revamp entitlement programs.
A new study published on the preprint server bioRxiv analyzes viral spike protein sequences from the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak in West Bengal, India, comparing them with sequences from other Indian states and Wuhan, China.
Mylan Inc. today announced that it intends to privately place $300 million in aggregate principal amount of senior notes through a reopening of its Senior Notes due 2020, subject to market and other conditions. The notes are being offered as additional notes under an existing indenture under which Mylan issued $700 million aggregate principal amount of Senior Notes due 2020 on May 19, 2010. The notes to be issued in this offering and the previously issued Senior Notes due 2020 will be treated as a single class of notes under the indenture.
› Verified 6 days ago
Entity Name | Montefiore New Rochelle Hospital |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1295163244 PECOS PAC ID: 0345474706 Enrollment ID: O20150310001611 |
News Archive
Arno Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing oncology therapeutics, today announced the dosing of the first patient in an investigator sponsored Phase I/IIa clinical study of AR-42 (formerly OSU-HDAC42) at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC-James) in adult patients with relapsed or refractory multiple myeloma (MM), chronic lymphocytic leukemia (CLL) or lymphoma.
The measure, which awaits the president's signature, puts off large cuts in federal spending and increases taxes. But it delays efforts to revamp entitlement programs.
A new study published on the preprint server bioRxiv analyzes viral spike protein sequences from the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak in West Bengal, India, comparing them with sequences from other Indian states and Wuhan, China.
Mylan Inc. today announced that it intends to privately place $300 million in aggregate principal amount of senior notes through a reopening of its Senior Notes due 2020, subject to market and other conditions. The notes are being offered as additional notes under an existing indenture under which Mylan issued $700 million aggregate principal amount of Senior Notes due 2020 on May 19, 2010. The notes to be issued in this offering and the previously issued Senior Notes due 2020 will be treated as a single class of notes under the indenture.
› Verified 6 days ago
Entity Name | Montefiore Mount Vernon Hospital |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1013345065 PECOS PAC ID: 7810122231 Enrollment ID: O20150423000849 |
News Archive
Arno Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing oncology therapeutics, today announced the dosing of the first patient in an investigator sponsored Phase I/IIa clinical study of AR-42 (formerly OSU-HDAC42) at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC-James) in adult patients with relapsed or refractory multiple myeloma (MM), chronic lymphocytic leukemia (CLL) or lymphoma.
The measure, which awaits the president's signature, puts off large cuts in federal spending and increases taxes. But it delays efforts to revamp entitlement programs.
A new study published on the preprint server bioRxiv analyzes viral spike protein sequences from the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak in West Bengal, India, comparing them with sequences from other Indian states and Wuhan, China.
Mylan Inc. today announced that it intends to privately place $300 million in aggregate principal amount of senior notes through a reopening of its Senior Notes due 2020, subject to market and other conditions. The notes are being offered as additional notes under an existing indenture under which Mylan issued $700 million aggregate principal amount of Senior Notes due 2020 on May 19, 2010. The notes to be issued in this offering and the previously issued Senior Notes due 2020 will be treated as a single class of notes under the indenture.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Stephen Carl Klass, MD 421 Huguenot St, New Rochelle, NY 10801-7004 Ph: (914) 636-4418 | Dr Stephen Carl Klass, MD 421 Huguenot St, New Rochelle, NY 10801-7004 Ph: (914) 636-4418 |
News Archive
Arno Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing oncology therapeutics, today announced the dosing of the first patient in an investigator sponsored Phase I/IIa clinical study of AR-42 (formerly OSU-HDAC42) at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC-James) in adult patients with relapsed or refractory multiple myeloma (MM), chronic lymphocytic leukemia (CLL) or lymphoma.
The measure, which awaits the president's signature, puts off large cuts in federal spending and increases taxes. But it delays efforts to revamp entitlement programs.
A new study published on the preprint server bioRxiv analyzes viral spike protein sequences from the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak in West Bengal, India, comparing them with sequences from other Indian states and Wuhan, China.
Mylan Inc. today announced that it intends to privately place $300 million in aggregate principal amount of senior notes through a reopening of its Senior Notes due 2020, subject to market and other conditions. The notes are being offered as additional notes under an existing indenture under which Mylan issued $700 million aggregate principal amount of Senior Notes due 2020 on May 19, 2010. The notes to be issued in this offering and the previously issued Senior Notes due 2020 will be treated as a single class of notes under the indenture.
› Verified 6 days ago
Thomas M Collins, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 420 North Ave, New Rochelle Services Of Rpc Second Floor, New Rochelle, NY 10801 Phone: 914-633-8842 Fax: 914-633-8947 | |
Dr. Lidia Lidagoster, MEDICAL DOCTOR Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 175 Memorial Hwy Ste Ll7, New Rochelle, NY 10801 Phone: 212-707-8662 Fax: 212-582-0888 | |
Dr. Lita Lyakhovetskaya, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 420 North Ave, 2nd Floor, New Rochelle, NY 10801 Phone: 914-633-8842 Fax: 914-633-8947 | |
Wendy L Irwin, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 60 Hillside Ln, New Rochelle, NY 10804 Phone: 914-441-7789 | |
Nyarai Florence Henry, PMHNP-BC Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 435 Webster Ave Apt 3b, New Rochelle, NY 10801 Phone: 914-540-4098 | |
Enrique J Teuscher, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 47 Stonelea Pl, New Rochelle, NY 10801 Phone: 914-576-1318 Fax: 914-576-1510 | |
Sheldon Marc Wasserman, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 421 Huguenot Street, New Rochelle, NY 10801 Phone: 914-636-4418 Fax: 914-636-2975 |